Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 368 de 371.

Grafa
Technology

Corteva and Hexagon Bio form JV to fast-track nature-derived crop protection

Corteva (NYSE:CTVA), the agricultural technology giant, and Hexagon Bio, a biotechnology company focused on nature-derived therapeutics, announced a multi-million-dollar joint venture aimed at accelerating the discovery of new crop protection solutions.

Leia mais: Corteva and Hexagon Bio form JV to fast-track nature-derived crop protection
Grafa
Health

Cosette Pharma wins FDA approval for first generic CIPRO HC with 180-day exclusivity

Cosette Pharmaceuticals said the U.S. Food and Drug Administration has approved its abbreviated new drug application for the first generic version of CIPRO HC, granting the company 180 days of Competitive Generic Therapy exclusivity and ending a more than 27-year stretch without a generic alternative.

Leia mais: Cosette Pharma wins FDA approval for first generic CIPRO HC with 180-day exclusivity
Grafa
Health

Palvella wins FDA fast track status for QTORIN rapamycin gel in angiokeratomas

Palvella Therapeutics (NASDAQ:PVLA) said the U.S. Food and Drug Administration has granted Fast Track Designation to QTORIN 3.9% rapamycin anhydrous gel for treating angiokeratomas, a dermatologic condition with no currently approved therapies.

Leia mais: Palvella wins FDA fast track status for QTORIN rapamycin gel in angiokeratomas
Grafa
Health

Nektar’s alopecia drug shows hair-regrowth benefit but misses primary endpoint in Phase 2b trial

Nektar Therapeutics (NASDAQ:NKTR) reported mixed Phase 2b results for rezpegaldesleukin in severe-to-very-severe alopecia areata, showing meaningful clinical activity but narrowly missing the trial’s primary endpoint in the modified intent-to-treat population.

Leia mais: Nektar’s alopecia drug shows hair-regrowth benefit but misses primary endpoint in Phase 2b trial
Grafa

Apollo to acquire majority stake in French fresh-food retailer Prosol Group from Ardian

Apollo Global Management (NYSE:APO) has agreed to acquire a majority stake in Prosol Group, the French fresh-food retail platform best known for its Grand Frais and Fresh store networks, from private equity firm Ardian.

Leia mais: Apollo to acquire majority stake in French fresh-food retailer Prosol Group from Ardian
Grafa
Health

Bicycle Therapeutics secures 400-tonne reprocessed uranium supply in 15-year NDA deal

Bicycle Therapeutics (NASDAQ:BCYC), developer of a novel class of bicyclic peptide-based medicines, has secured a 15-year contract with the UK Nuclear Decommissioning Authority granting access to up to 400 tonnes of reprocessed uranium (RepU)—a resource the company says will underpin long-term production of lead-212 (212Pb) for its emerging cancer radioconjugate programs.

Leia mais: Bicycle Therapeutics secures 400-tonne reprocessed uranium supply in 15-year NDA deal
Grafa

PayPal files to create FDIC-insured industrial bank in Utah

PayPal Holdings (NASDAQ:PYPL) has taken a significant step toward expanding its regulated financial-services operations, filing applications on Dec. 15, 2025 with both the Utah Department of Financial Institutions and the Federal Deposit Insurance Corporation to establish PayPal Bank, a Utah-chartered industrial loan company (ILC).

Leia mais: PayPal files to create FDIC-insured industrial bank in Utah